|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:alsoKnownAs
|
gptkb:monkeypox
|
|
gptkbp:animalReservoir
|
rodents
primates
|
|
gptkbp:causedBy
|
gptkb:monkeypox_virus
orthopoxvirus
|
|
gptkbp:contagiousPeriod
|
from symptom onset until lesions scab over
|
|
gptkbp:diagnosedBy
|
serology
virus isolation
PCR testing
|
|
gptkbp:endemicTo
|
gptkb:Central_Africa
gptkb:West_Africa
|
|
gptkbp:family
|
gptkb:Poxviridae
|
|
gptkbp:firstDescribed
|
1958
|
|
gptkbp:firstHumanCase
|
1970
|
|
gptkbp:genomeType
|
double-stranded DNA
|
|
gptkbp:genus
|
gptkb:Orthopoxvirus
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
mpox
|
|
gptkbp:incubationPeriod
|
5-21 days
|
|
gptkbp:mortalityRate
|
1-10%
higher in immunocompromised individuals
higher in children
|
|
gptkbp:notableFeature
|
lymphadenopathy distinguishes from smallpox
|
|
gptkbp:notableOutbreaks
|
gptkb:United_States_2003
Nigeria 2017-2018
|
|
gptkbp:outbreak
|
2022 global outbreak
|
|
gptkbp:prevention
|
gptkb:JYNNEOS_vaccine
smallpox vaccine
avoid contact with infected individuals
|
|
gptkbp:relatedTo
|
gptkb:smallpox
gptkb:vaccinia_virus
gptkb:cowpox
|
|
gptkbp:symptom
|
fever
fatigue
headache
muscle aches
chills
rash
lymphadenopathy
|
|
gptkbp:transmission
|
respiratory droplets
close contact
contact with contaminated materials
animal to human
human to human
|
|
gptkbp:treatment
|
gptkb:tecovirimat
supportive care
|
|
gptkbp:WHODeclaredPublicHealthEmergency
|
2022
|
|
gptkbp:zoonotic
|
true
|
|
gptkbp:bfsParent
|
gptkb:monkeypox
gptkb:2022–2023_global_outbreak
|
|
gptkbp:bfsLayer
|
6
|